120 related articles for article (PubMed ID: 35723196)
1. NPM1 is a diagnostic and prognostic biomarker associated with the clinicopathological characteristics of gastric cancer.
Guo CA; Su XL; Wang WJ; Xia TH; Cao XM; Yuan SB; Wang WA; Zhang A; Liu HB
Neoplasma; 2022 Jul; 69(4):965-975. PubMed ID: 35723196
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications.
Leal MF; Mazzotti TK; Calcagno DQ; Cirilo PD; Martinez MC; Demachki S; Assumpção PP; Chammas R; Burbano RR; Smith MC
BMC Gastroenterol; 2014 Jan; 14():9. PubMed ID: 24410879
[TBL] [Abstract][Full Text] [Related]
3. Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.
Yu X; Ding H; Shi Y; Yang L; Zhou J; Yan Z; Xiao B
Dis Markers; 2020; 2020():7347298. PubMed ID: 33163123
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
He XY; Zhao J; Chen ZQ; Jin R; Liu CY
Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
[TBL] [Abstract][Full Text] [Related]
5. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
[TBL] [Abstract][Full Text] [Related]
6. Lysyl oxidase and hypoxia-inducible factor 1α: biomarkers of gastric cancer.
Han YL; Chen L; Qin R; Wang GQ; Lin XH; Dai GH
World J Gastroenterol; 2019 Apr; 25(15):1828-1839. PubMed ID: 31057297
[TBL] [Abstract][Full Text] [Related]
7. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
8. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers.
Zhou F; Qiu W; Sun L; Xiang J; Sun X; Sui A; Ding A; Yue L
APMIS; 2013 Jul; 121(7):582-91. PubMed ID: 23489260
[TBL] [Abstract][Full Text] [Related]
10. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
13. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract][Full Text] [Related]
14. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
[TBL] [Abstract][Full Text] [Related]
15. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis.
Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N
Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079
[No Abstract] [Full Text] [Related]
16. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
17. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
18. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of circRNA hsa_circ_0067582 in human gastric cancer and its potential diagnostic values.
Yu X; Ding H; Yang L; Yu Y; Zhou J; Yan Z; Guo J
J Clin Lab Anal; 2020 Mar; 34(3):e23080. PubMed ID: 31721300
[TBL] [Abstract][Full Text] [Related]
20. Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.
Liu SS; Wan QS; Lv C; Wang JK; Jiang S; Cai D; Liu MS; Wang T; Zhang KH
BMC Cancer; 2024 Apr; 24(1):465. PubMed ID: 38622522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]